Φορτώνει......
Treatment of metastatic refractory colorectal cancer following regorafenib failure
At present, there is no set strategy for the treatment of patients with colorectal cancer subsequent to the failure of standard treatment, other than the use of regorafenib (RGR) and TAS-102. The best order in which to use these drugs, and their safety and efficacy in combination with other drugs, a...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Mol Clin Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
D.A. Spandidos
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5532698/ https://ncbi.nlm.nih.gov/pubmed/28781808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1307 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|